Page last updated: 2024-11-08

dromostanolone propionate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

dromostanolone propionate: RN given refers to (2alpha,5alpha,17beta)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID224004
CHEMBL ID1201048
CHEBI ID31523
SCHEMBL ID3173
MeSH IDM0050834

Synonyms (93)

Synonym
x20uz57g4o ,
unii-x20uz57g4o
dromostanolone propionate [usan:usp]
nomasteron
4-08-00-00654 (beilstein handbook reference)
2alpha-methyl-4,5-dihydrotestosterone propionate
einecs 208-303-1
testosterone, 4,5alpha-dihydro-2alpha-methyl-, propionate
medrotestrone propanoate
dromostanolone propionate [usan]
androstan-3-one, 2-methyl-17-(1-oxopropoxy)-, (2alpha,5alpha,17beta)-
ai3-52810
5-alpha-androstan-3-one, 17-beta-hydroxy-2-alpha-methyl-, propionate
androstan-3-one, 2-methyl-17-(1-oxopropoxy)-
17beta-hydroxy-2alpha-methyl-5alpha-androstan-3-one propionate
brn 3161958
medrotestrone propionate
dromostanolone proprionate
(2alpha,5alpha,17beta)-2-methyl-3-oxoandrostan-17-yl propanoate
nsc-1298
testosterone,5.alpha.-dihydro-2.alpha.-methyl-, propionate
2.alpha.-methyldihydrotestosterone propionate
emdisterone
dromostanolone propionate
drolban
2.alpha.-methyl-4,5-dihydrotestosterone propionate
2mdtp
rs 1567
drostanolone propionate
masterid
nsc-12198
521-12-0
permastril
nsc12198
17.beta.-hydroxy-2.alpha.-methyl-5.alpha.-androstan-3-one propionate
masteril
masterone
mdht
medrotestron propionate
2m-dhtp
re 346
lilly 32379
blackburn compound
C15917
2alpha-methyl-3-oxo-5alpha-androstan-17beta-yl propanoate
CHEBI:31523 ,
D01534
drostanolone propionate (jan)
drolban (tn)
dromostanolone propionate (usan)
masteron (tn)
CHEMBL1201048
masteron
[(2r,5s,8r,9s,10s,13s,14s,17s)-2,10,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl] propanoate
propanoic acid [(2r,5s,8r,9s,10s,13s,14s,17s)-2,10,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl] ester
A828929
[(2r,5s,8r,9s,10s,13s,14s,17s)-2,10,13-trimethyl-3-oxidanylidene-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl] propanoate
AKOS015895157
S4794
gtpl6947
dromostanolone propionate [orange book]
drostanolone propionate [jan]
dromostanolone propionate [mi]
drostanolone propionate [who-dd]
drostanolone propionate [mart.]
androstan-3-one, 2-methyl-17-(1-oxopropoxy)-, (2.alpha.,5.alpha.,17.beta
SCHEMBL3173
dromostanolone 17-propionate
W-105852
androstan-3-one, 2-methyl-17-(1-oxopropoxy)-, (2a,5a,17b)-
2-methyl-3-oxoandrostan-17-yl propionate, (2.alpha.,5.alpha.,17.beta.)- #
NOTIQUSPUUHHEH-UXOVVSIBSA-N
5.alpha.-androstan-3-one, 17.beta.-hydroxy-2.alpha.-methyl-, propionate
testosterone, 4,5.alpha.-dihydro-2.alpha.-methyl-, propionate
DTXSID1022972
androstan-3-one,2-methyl-17-(1-oxopropoxy)-,(2|a,5|a,17|a)-
DS-3972
Q5308606
DB14655
(2r,5s,8r,9s,10s,13s,14s,17s)-2,10,13-trimethyl-3-oxohexadecahydro-1h-cyclopenta[a]phenanthren-17-yl propionate
CCG-268166
NCGC00507798-01
CS-0028187
HY-107344
drostanolone propionate 100 microg/ml in acetonitrile
2alpha-methyl-3-oxo-5alpha-androstan-17beta-yl propionate
2alpha-methyldihydrotestosterone propionate
drostanolone propionate (mart.)
compound 32379
dromostanolone propionate (usan:usp)
2 alpha-methyldihydrotestosterone propionate
2-alpha-methyldihydrotestosterone propionate
androstan-3-one, 2-methyl-17-(1-oxopropoxy)-, (2alpha,5alpha,17.beta
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
steroid ester
3-oxo-5alpha-steroidA 3-oxo steroid that has alpha configuration at position 5.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Spike glycoproteinSevere acute respiratory syndrome-related coronavirusPotency39.81070.009610.525035.4813AID1479145
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
virion membraneSpike glycoproteinSevere acute respiratory syndrome-related coronavirus
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID588220Literature-mined public compounds from Kruhlak et al phospholipidosis modelling dataset2008Toxicology mechanisms and methods, , Volume: 18, Issue:2-3
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (71.43)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 59.39

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index59.39 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index94.94 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (59.39)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (11.11%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (11.11%)4.05%
Observational0 (0.00%)0.25%
Other7 (77.78%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]